At Broadstreet we deliver solutions not formulas.
An open-minded and client-focused approach means our customized design process delivers the solution you need.
Broadstreet is a boutique technology solutions company for the health economics and outcomes research community. We were founded on the idea that good research begins with a solid client-consultant relationship. We consistently deliver high-quality technology solutions for two key reasons.
We only take on work we know we’re great at and, more importantly, we put the client at the center of the process.
Epidemiology & Observational Studies
Our team designs and conducts observational studies used to characterize the clinical landscape and burden of disease for a product’s indication; estimate treatment effectiveness or safety; or parameterize economic models.
We provide rigorously conducted literature reviews following best practices guidelines, coupled with robust quantitative or qualitative evidence syntheses, to address a variety of research questions.
Our team develops HEOR models for a variety of contexts and settings. Our approach to model development and adaptation is to work with clients to design a customized structure and interface, in accordance with submission requirements and guidelines for best practice.
HEOR Technology Services
We have the IT capability to undertake big solutions. We create a variety of high-quality, custom digital products for our clients. These include tools that ensure for timely and accurate data collection, digital models that facilitate data analysis, and novel tools for dissemination of study findings.
To all our Broadstreet friends, I know it has been a while since you heard from us. We hope you are all doing well during these strange, strange times we are living in. Like for most people around the world, […]
Broadstreet is off to Copenhagen this week! We are looking forward to exploring the city’s canals, enjoying some fine food and of course, taking in ISPOR Europe 2019. We will be presenting a number of posters this year, including: Comprehensive […]
This year, Broadstreet’s Karissa Johnston will be moderating an issue panel on the topic of single-arm trials for novel therapies. The session: Single-arm trials of novel therapies. Too good for approval, but not good enough for reimbursement? will be […]